Iron deficiency is a silent threat to pregnant women, but a groundbreaking quality improvement project is turning the tide. Dr. Richard Godby and his team at the Mayo Clinic have achieved a remarkable sixfold increase in iron deficiency screening rates within just a year.
But here's where it gets controversial: current guidelines recommend screening only for anemia, defined as a hemoglobin level below 11 g/dL. Dr. Godby's project challenges this norm, advocating for a broader approach to iron deficiency management during pregnancy.
The project's success is evident: screening rates soared from a mere 10% to an impressive 63%, and the number of intravenous iron infusions skyrocketed by 20 times. Median hemoglobin levels also saw a significant improvement.
Dr. Godby emphasizes the high risk of iron deficiency among women of child-bearing age, attributing it to menstruation and low iron intake. He also highlights the impact of certain medications on iron absorption.
Iron deficiency during pregnancy can lead to adverse outcomes for both mother and child, including fetal growth restriction and compromised brain and nervous system development.
To address this, Dr. Godby and his colleagues implemented ferritin testing, a protein-based blood test, at specific stages of pregnancy. If low ferritin levels were detected, oral supplements or IV infusions of iron dextran were offered.
The results speak for themselves: a dramatic increase in screening and treatment, with a notable improvement in median hemoglobin levels.
And this is the part most people miss: the project's potential impact on postpartum care. Dr. Godby suggests that treating iron deficiency during pregnancy could reduce the need for blood transfusions after delivery, a benefit that deserves further exploration.
The team's next step is to analyze the impact of iron deficiency treatment on patients' quality of life, including post-partum depression and return to work.
This groundbreaking project not only improves screening rates but also challenges conventional guidelines, offering a new perspective on iron deficiency management during pregnancy.
Dr. Richard Godby will present these findings at the Orange County Convention Center on December 7, 2025, at 12:00 noon Eastern time.
A thought-provoking question for our readers: Should guidelines be revised to prioritize iron deficiency screening during pregnancy, given the potential benefits and the high prevalence of this issue? Share your thoughts in the comments!
